| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Skeletal | 15 | 2024 | 939 | 3.070 |
Why?
|
| Muscle Strength | 12 | 2024 | 75 | 2.360 |
Why?
|
| High-Intensity Interval Training | 3 | 2022 | 3 | 1.670 |
Why?
|
| Spatial Navigation | 3 | 2022 | 27 | 1.590 |
Why?
|
| Dietary Supplements | 12 | 2024 | 472 | 1.560 |
Why?
|
| Fasting | 5 | 2022 | 298 | 1.540 |
Why?
|
| Creatine | 3 | 2018 | 41 | 1.390 |
Why?
|
| Resistance Training | 7 | 2022 | 32 | 1.240 |
Why?
|
| Exercise | 11 | 2022 | 816 | 1.080 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2024 | 680 | 1.030 |
Why?
|
| DNA-Directed RNA Polymerases | 2 | 2025 | 121 | 0.990 |
Why?
|
| DNA Damage | 2 | 2025 | 512 | 0.940 |
Why?
|
| Synbiotics | 1 | 2024 | 7 | 0.920 |
Why?
|
| Hand Strength | 1 | 2024 | 41 | 0.910 |
Why?
|
| Sarcopenia | 1 | 2024 | 39 | 0.880 |
Why?
|
| DNA Replication | 2 | 2025 | 350 | 0.870 |
Why?
|
| Conjugation, Genetic | 1 | 2023 | 9 | 0.850 |
Why?
|
| Body Composition | 9 | 2024 | 516 | 0.850 |
Why?
|
| Type IV Secretion Systems | 1 | 2023 | 7 | 0.850 |
Why?
|
| Transcription, Genetic | 2 | 2025 | 1702 | 0.810 |
Why?
|
| Obesity | 8 | 2022 | 2233 | 0.800 |
Why?
|
| Physical Conditioning, Animal | 2 | 2020 | 91 | 0.710 |
Why?
|
| Energy Intake | 2 | 2020 | 489 | 0.690 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2019 | 15 | 0.680 |
Why?
|
| Adipose Tissue, White | 1 | 2020 | 79 | 0.670 |
Why?
|
| Ghrelin | 1 | 2019 | 53 | 0.660 |
Why?
|
| Recovery of Function | 4 | 2018 | 437 | 0.650 |
Why?
|
| Diet, High-Fat | 2 | 2020 | 211 | 0.650 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1078 | 0.650 |
Why?
|
| Hypothalamus | 1 | 2020 | 217 | 0.620 |
Why?
|
| Metabolic Syndrome | 1 | 2022 | 331 | 0.620 |
Why?
|
| Whey Proteins | 1 | 2018 | 6 | 0.610 |
Why?
|
| Isometric Contraction | 1 | 2018 | 22 | 0.610 |
Why?
|
| Diet Fads | 1 | 2018 | 1 | 0.610 |
Why?
|
| Myalgia | 1 | 2018 | 11 | 0.600 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2015 | 63 | 0.600 |
Why?
|
| Muscle Development | 1 | 2018 | 71 | 0.590 |
Why?
|
| Microbiota | 1 | 2022 | 391 | 0.580 |
Why?
|
| Lipoproteins, LDL | 1 | 2018 | 116 | 0.580 |
Why?
|
| Muscular Diseases | 1 | 2018 | 102 | 0.570 |
Why?
|
| Maze Learning | 4 | 2022 | 127 | 0.550 |
Why?
|
| Oxidative Stress | 4 | 2018 | 795 | 0.540 |
Why?
|
| Physical Fitness | 2 | 2013 | 91 | 0.530 |
Why?
|
| Hyperlipidemias | 1 | 2018 | 173 | 0.530 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 2524 | 0.530 |
Why?
|
| Diet | 7 | 2022 | 1130 | 0.510 |
Why?
|
| Regeneration | 1 | 2018 | 202 | 0.510 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 130 | 0.500 |
Why?
|
| Energy Metabolism | 3 | 2019 | 770 | 0.490 |
Why?
|
| Muscular Atrophy | 1 | 2015 | 74 | 0.480 |
Why?
|
| Life Style | 2 | 2017 | 404 | 0.480 |
Why?
|
| Insulin Resistance | 2 | 2018 | 641 | 0.480 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 763 | 0.480 |
Why?
|
| Software | 1 | 2019 | 675 | 0.470 |
Why?
|
| Dietary Carbohydrates | 4 | 2022 | 118 | 0.450 |
Why?
|
| Weight Loss | 5 | 2022 | 480 | 0.450 |
Why?
|
| Genotype | 1 | 2019 | 2533 | 0.440 |
Why?
|
| Physiology | 2 | 2023 | 14 | 0.430 |
Why?
|
| Cardiovascular Diseases | 2 | 2022 | 1877 | 0.420 |
Why?
|
| Male | 31 | 2024 | 60282 | 0.390 |
Why?
|
| Aging | 4 | 2013 | 1183 | 0.390 |
Why?
|
| Weight Gain | 3 | 2020 | 401 | 0.380 |
Why?
|
| Biomarkers | 8 | 2022 | 2948 | 0.350 |
Why?
|
| Carnosine | 1 | 2010 | 1 | 0.350 |
Why?
|
| MicroRNAs | 1 | 2017 | 829 | 0.350 |
Why?
|
| Inflammation | 9 | 2022 | 1403 | 0.350 |
Why?
|
| Double-Blind Method | 7 | 2024 | 1600 | 0.340 |
Why?
|
| beta-Alanine | 1 | 2010 | 8 | 0.340 |
Why?
|
| Humans | 46 | 2025 | 123305 | 0.340 |
Why?
|
| Overweight | 2 | 2022 | 358 | 0.330 |
Why?
|
| Australia | 3 | 2024 | 139 | 0.330 |
Why?
|
| Female | 25 | 2024 | 65618 | 0.320 |
Why?
|
| Blood Glucose | 4 | 2022 | 1122 | 0.310 |
Why?
|
| Muscle Proteins | 3 | 2018 | 416 | 0.310 |
Why?
|
| Adult | 24 | 2022 | 29087 | 0.300 |
Why?
|
| Inflammation Mediators | 4 | 2010 | 233 | 0.300 |
Why?
|
| Neurogenesis | 2 | 2020 | 196 | 0.290 |
Why?
|
| Curriculum | 2 | 2023 | 718 | 0.290 |
Why?
|
| Animals | 13 | 2022 | 33817 | 0.280 |
Why?
|
| Sex Characteristics | 2 | 2020 | 313 | 0.280 |
Why?
|
| Young Adult | 14 | 2022 | 8871 | 0.280 |
Why?
|
| Middle Aged | 19 | 2024 | 26075 | 0.270 |
Why?
|
| Physical Endurance | 3 | 2015 | 46 | 0.260 |
Why?
|
| Adiposity | 2 | 2018 | 191 | 0.260 |
Why?
|
| Adaptation, Physiological | 2 | 2020 | 260 | 0.260 |
Why?
|
| Boswellia | 2 | 2017 | 2 | 0.250 |
Why?
|
| Transcription Termination, Genetic | 1 | 2025 | 13 | 0.240 |
Why?
|
| Walking Speed | 1 | 2024 | 15 | 0.230 |
Why?
|
| Aged | 12 | 2024 | 19173 | 0.230 |
Why?
|
| Quality of Life | 1 | 2013 | 1932 | 0.230 |
Why?
|
| Golf | 1 | 2023 | 4 | 0.220 |
Why?
|
| Genome, Viral | 1 | 2024 | 170 | 0.210 |
Why?
|
| Genomic Instability | 1 | 2024 | 229 | 0.210 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2023 | 42 | 0.210 |
Why?
|
| Sports | 1 | 2023 | 59 | 0.210 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2017 | 280 | 0.210 |
Why?
|
| Range of Motion, Articular | 3 | 2018 | 73 | 0.210 |
Why?
|
| Mutation | 5 | 2024 | 5768 | 0.200 |
Why?
|
| Spatial Memory | 1 | 2022 | 37 | 0.190 |
Why?
|
| Goals | 2 | 2019 | 128 | 0.190 |
Why?
|
| Running | 3 | 2018 | 36 | 0.190 |
Why?
|
| Plasmids | 1 | 2023 | 511 | 0.190 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2019 | 155 | 0.190 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2017 | 716 | 0.190 |
Why?
|
| RNA, Viral | 1 | 2024 | 539 | 0.190 |
Why?
|
| Exercise Test | 3 | 2018 | 249 | 0.190 |
Why?
|
| Nutrition Assessment | 1 | 2022 | 133 | 0.180 |
Why?
|
| Gallbladder Neoplasms | 1 | 2020 | 13 | 0.180 |
Why?
|
| Physical Conditioning, Human | 1 | 2020 | 2 | 0.180 |
Why?
|
| Phytotherapy | 2 | 2013 | 50 | 0.180 |
Why?
|
| Virus Replication | 1 | 2024 | 603 | 0.180 |
Why?
|
| RNA, Messenger | 3 | 2020 | 2813 | 0.180 |
Why?
|
| Mice, Obese | 1 | 2020 | 78 | 0.170 |
Why?
|
| Mice | 4 | 2022 | 17546 | 0.170 |
Why?
|
| Soy Milk | 2 | 2010 | 3 | 0.170 |
Why?
|
| Torque | 2 | 2018 | 10 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4357 | 0.170 |
Why?
|
| Creatine Kinase | 2 | 2018 | 54 | 0.170 |
Why?
|
| B7-H1 Antigen | 1 | 2020 | 110 | 0.170 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 113 | 0.170 |
Why?
|
| Dietary Fats | 2 | 2020 | 296 | 0.160 |
Why?
|
| Leptin | 1 | 2020 | 214 | 0.160 |
Why?
|
| Diet, High-Protein | 1 | 2018 | 5 | 0.160 |
Why?
|
| Ankle Injuries | 1 | 2018 | 33 | 0.150 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 142 | 0.150 |
Why?
|
| Cytoprotection | 1 | 2018 | 39 | 0.150 |
Why?
|
| Plant Extracts | 2 | 2017 | 120 | 0.150 |
Why?
|
| Bupivacaine | 1 | 2018 | 21 | 0.150 |
Why?
|
| Rectal Neoplasms | 1 | 2019 | 76 | 0.150 |
Why?
|
| Diet, Western | 1 | 2018 | 17 | 0.150 |
Why?
|
| Lipid Peroxidation | 1 | 2018 | 81 | 0.150 |
Why?
|
| Military Personnel | 1 | 2020 | 208 | 0.150 |
Why?
|
| Exercise Tolerance | 1 | 2018 | 77 | 0.150 |
Why?
|
| Neuronal Plasticity | 1 | 2020 | 273 | 0.150 |
Why?
|
| Hippocampus | 2 | 2020 | 819 | 0.140 |
Why?
|
| Cognition | 1 | 2022 | 739 | 0.140 |
Why?
|
| Bacterial Proteins | 1 | 2023 | 878 | 0.140 |
Why?
|
| Eicosanoids | 1 | 2017 | 13 | 0.140 |
Why?
|
| Glucose Intolerance | 1 | 2018 | 75 | 0.140 |
Why?
|
| DNA Repair | 1 | 2020 | 579 | 0.140 |
Why?
|
| Patient Compliance | 2 | 2018 | 470 | 0.140 |
Why?
|
| Random Allocation | 1 | 2018 | 428 | 0.140 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 4289 | 0.140 |
Why?
|
| Curcumin | 1 | 2017 | 41 | 0.140 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 246 | 0.140 |
Why?
|
| Sarcoma | 1 | 2019 | 194 | 0.140 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2019 | 240 | 0.140 |
Why?
|
| Insulin | 2 | 2019 | 1205 | 0.130 |
Why?
|
| Perception | 1 | 2018 | 220 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 606 | 0.130 |
Why?
|
| Kidney | 1 | 2023 | 1335 | 0.130 |
Why?
|
| Memory | 1 | 2019 | 362 | 0.130 |
Why?
|
| Microsatellite Instability | 3 | 2020 | 36 | 0.130 |
Why?
|
| Health Status | 2 | 2018 | 375 | 0.130 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 6387 | 0.130 |
Why?
|
| Postmenopause | 3 | 2010 | 125 | 0.120 |
Why?
|
| Biomarkers, Tumor | 2 | 2020 | 1439 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 1217 | 0.120 |
Why?
|
| Glucose | 1 | 2019 | 876 | 0.120 |
Why?
|
| Dystrophin | 1 | 2014 | 37 | 0.120 |
Why?
|
| Electron Transport Complex I | 1 | 2014 | 31 | 0.120 |
Why?
|
| Alleles | 1 | 2019 | 1603 | 0.120 |
Why?
|
| Kidney Neoplasms | 1 | 2019 | 434 | 0.120 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 1239 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3382 | 0.110 |
Why?
|
| Narration | 1 | 2013 | 29 | 0.110 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 287 | 0.110 |
Why?
|
| Leucine | 1 | 2015 | 310 | 0.110 |
Why?
|
| Curcuma | 1 | 2013 | 1 | 0.110 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2014 | 75 | 0.110 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 561 | 0.110 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2015 | 341 | 0.100 |
Why?
|
| Geriatric Assessment | 1 | 2013 | 169 | 0.100 |
Why?
|
| Genetic Variation | 1 | 2019 | 1479 | 0.100 |
Why?
|
| Neoplasm Proteins | 2 | 2020 | 668 | 0.100 |
Why?
|
| Age Factors | 4 | 2020 | 2805 | 0.100 |
Why?
|
| Milk | 2 | 2010 | 118 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2014 | 667 | 0.100 |
Why?
|
| Universities | 2 | 2023 | 128 | 0.100 |
Why?
|
| Racquet Sports | 1 | 2012 | 1 | 0.100 |
Why?
|
| Sirolimus | 1 | 2014 | 220 | 0.100 |
Why?
|
| Peptide Hydrolases | 2 | 2011 | 141 | 0.100 |
Why?
|
| Athletic Performance | 1 | 2012 | 9 | 0.100 |
Why?
|
| Muscle Contraction | 2 | 2010 | 186 | 0.100 |
Why?
|
| Mutation Rate | 2 | 2024 | 66 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2024 | 12168 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2019 | 1523 | 0.100 |
Why?
|
| Motor Skills | 1 | 2012 | 83 | 0.100 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2011 | 5 | 0.100 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2011 | 11 | 0.090 |
Why?
|
| Fish Oils | 1 | 2012 | 82 | 0.090 |
Why?
|
| Docosahexaenoic Acids | 1 | 2012 | 66 | 0.090 |
Why?
|
| Milk Proteins | 1 | 2011 | 91 | 0.090 |
Why?
|
| Food, Formulated | 1 | 2011 | 52 | 0.090 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2011 | 25 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2017 | 3043 | 0.090 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2012 | 79 | 0.090 |
Why?
|
| Brain | 1 | 2022 | 2967 | 0.090 |
Why?
|
| Interleukin-6 | 4 | 2014 | 395 | 0.090 |
Why?
|
| NF-kappa B | 2 | 2010 | 457 | 0.090 |
Why?
|
| Neurons | 1 | 2020 | 1938 | 0.090 |
Why?
|
| Mitochondria | 1 | 2014 | 677 | 0.080 |
Why?
|
| Rats, Long-Evans | 2 | 2020 | 103 | 0.080 |
Why?
|
| Plant Preparations | 1 | 2009 | 18 | 0.080 |
Why?
|
| Adolescent | 8 | 2020 | 19132 | 0.080 |
Why?
|
| Dietary Proteins | 3 | 2020 | 242 | 0.080 |
Why?
|
| Enzymes | 1 | 2009 | 51 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2010 | 426 | 0.080 |
Why?
|
| Cyclooxygenase 2 | 4 | 2010 | 158 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 367 | 0.080 |
Why?
|
| Sex Factors | 3 | 2018 | 1263 | 0.080 |
Why?
|
| Ephedra | 1 | 2008 | 2 | 0.080 |
Why?
|
| Health Promotion | 1 | 2011 | 390 | 0.070 |
Why?
|
| Genomics | 3 | 2020 | 1474 | 0.070 |
Why?
|
| Caffeine | 1 | 2008 | 71 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 524 | 0.070 |
Why?
|
| Central Nervous System Stimulants | 1 | 2008 | 125 | 0.070 |
Why?
|
| Glutathione Peroxidase | 3 | 2013 | 32 | 0.070 |
Why?
|
| DNA Polymerase III | 1 | 2025 | 27 | 0.060 |
Why?
|
| Superoxide Dismutase | 3 | 2010 | 139 | 0.060 |
Why?
|
| DNA, Single-Stranded | 1 | 2025 | 73 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2014 | 4495 | 0.060 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2025 | 132 | 0.060 |
Why?
|
| Time Factors | 4 | 2018 | 6228 | 0.050 |
Why?
|
| Genome, Human | 2 | 2020 | 1265 | 0.050 |
Why?
|
| Body Weight | 2 | 2022 | 1002 | 0.050 |
Why?
|
| Athletes | 1 | 2023 | 61 | 0.050 |
Why?
|
| Basal Metabolism | 2 | 2014 | 93 | 0.050 |
Why?
|
| Appetite | 1 | 2022 | 36 | 0.050 |
Why?
|
| Hunger | 1 | 2022 | 50 | 0.050 |
Why?
|
| Caloric Restriction | 1 | 2022 | 85 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2023 | 203 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 375 | 0.050 |
Why?
|
| Nutritional Status | 1 | 2023 | 305 | 0.050 |
Why?
|
| Hypoxia | 1 | 2022 | 248 | 0.050 |
Why?
|
| Recommended Dietary Allowances | 1 | 2020 | 23 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2024 | 673 | 0.040 |
Why?
|
| Cross-Over Studies | 2 | 2014 | 310 | 0.040 |
Why?
|
| Interleukin-1beta | 2 | 2012 | 159 | 0.040 |
Why?
|
| Rats, Transgenic | 1 | 2019 | 15 | 0.040 |
Why?
|
| Learning | 1 | 2023 | 361 | 0.040 |
Why?
|
| Oxygen Consumption | 2 | 2011 | 307 | 0.040 |
Why?
|
| Nutritional Requirements | 1 | 2020 | 177 | 0.040 |
Why?
|
| Consensus | 1 | 2023 | 610 | 0.040 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2019 | 27 | 0.040 |
Why?
|
| Habits | 1 | 2019 | 26 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2025 | 983 | 0.040 |
Why?
|
| Single-Blind Method | 2 | 2010 | 235 | 0.040 |
Why?
|
| Smad4 Protein | 1 | 2019 | 55 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 74 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2022 | 559 | 0.040 |
Why?
|
| Interleukins | 2 | 2009 | 118 | 0.040 |
Why?
|
| Homeostasis | 1 | 2022 | 683 | 0.040 |
Why?
|
| United Kingdom | 1 | 2018 | 190 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 569 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 467 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2019 | 164 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2018 | 6032 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2020 | 992 | 0.030 |
Why?
|
| Body Mass Index | 2 | 2014 | 1551 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 501 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 1084 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 1213 | 0.030 |
Why?
|
| Pain | 1 | 2018 | 470 | 0.030 |
Why?
|
| Citrate (si)-Synthase | 1 | 2014 | 19 | 0.030 |
Why?
|
| Muscle Stretching Exercises | 1 | 2014 | 2 | 0.030 |
Why?
|
| Ergometry | 1 | 2014 | 5 | 0.030 |
Why?
|
| Muscle Fatigue | 1 | 2014 | 7 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 718 | 0.030 |
Why?
|
| Citric Acid Cycle | 1 | 2014 | 44 | 0.030 |
Why?
|
| Recurrence | 1 | 2018 | 1419 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2014 | 146 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2014 | 219 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2014 | 26 | 0.030 |
Why?
|
| Diaphragm | 1 | 2014 | 99 | 0.030 |
Why?
|
| Affect | 1 | 2014 | 159 | 0.030 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2014 | 78 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1801 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 3664 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 1872 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 1390 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2013 | 269 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2011 | 45 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2844 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2011 | 75 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 66 | 0.020 |
Why?
|
| Receptor, Insulin | 1 | 2011 | 67 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 426 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 488 | 0.020 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2011 | 95 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 424 | 0.020 |
Why?
|
| Antioxidants | 1 | 2013 | 338 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 406 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 664 | 0.020 |
Why?
|
| Movement | 1 | 2012 | 170 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2011 | 211 | 0.020 |
Why?
|
| Cattle | 1 | 2011 | 557 | 0.020 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2010 | 13 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2011 | 284 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 2011 | 225 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 4709 | 0.020 |
Why?
|
| Basophils | 1 | 2009 | 11 | 0.020 |
Why?
|
| Dinoprost | 1 | 2009 | 28 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2010 | 54 | 0.020 |
Why?
|
| Creatine Kinase, MM Form | 1 | 2009 | 6 | 0.020 |
Why?
|
| Quadriceps Muscle | 1 | 2009 | 12 | 0.020 |
Why?
|
| Texas | 1 | 2018 | 3568 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1011 | 0.020 |
Why?
|
| Calcium | 1 | 2014 | 1098 | 0.020 |
Why?
|
| Soybean Proteins | 1 | 2009 | 18 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 4515 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2009 | 76 | 0.020 |
Why?
|
| Isoflavones | 1 | 2009 | 44 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2011 | 449 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2009 | 247 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2009 | 169 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2009 | 115 | 0.020 |
Why?
|
| Eosinophils | 1 | 2009 | 121 | 0.020 |
Why?
|
| Heart Rate | 1 | 2011 | 587 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2011 | 349 | 0.020 |
Why?
|
| Weight Lifting | 1 | 2008 | 6 | 0.020 |
Why?
|
| Physical Education and Training | 1 | 2008 | 20 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 1415 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2009 | 669 | 0.020 |
Why?
|
| Neutrophils | 1 | 2009 | 373 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1584 | 0.020 |
Why?
|
| Apoptosis | 1 | 2011 | 1787 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 10042 | 0.010 |
Why?
|
| United States | 1 | 2019 | 10667 | 0.010 |
Why?
|
| Cytokines | 1 | 2009 | 1284 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 5050 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 1661 | 0.010 |
Why?
|